F. LeMoine, Sami Backley, Gustavo Vilchez-Lagos, Jimmy Espinoza, E. Hernandez-Andrade, Anthony Johnson, R. Papanna, Eric P. Bergh
2026.1.20FETAL DIAGNOSIS AND THERAPY
tlooto Summary
Observed associations with perioperative factors, particularly with CAS, may inform detailed post-FLP evaluation for PABS and early detection of PABS may facilitate prenatal intervention and reduce adverse neonatal outcomes.
Abstract
OBJECTIVE Pseudoamniotic band sequence (PABS) is a rare but serious complication following fetoscopic laser photocoagulation (FLP) for twin-twin transfusion syndrome (TTTS). We aim to explore associations between perioperative factors and PABS in monochorionic, diamniotic twins undergoing FLP for TTTS.
METHODS A secondary analysis was conducted using a prospective cohort of 816 FLP procedures performed between 2011 and 2024 at a single fetal therapy center. All cases had confirmed absence of PABS prior to FLP via ultrasound and fetoscopic evaluation. PABS was diagnosed postnatally or suspected after FLP and confirmed after birth. Clinical and perioperative variables were compared between cases with and without PABS using appropriate two-sample tests, with statistical significance set at p<0.01 to minimize type I error in a smaller cohort.
RESULTS PABS occurred in 11 cases (1.3%), with only 3 (27.3%) identified prenatally and treated with in utero band lysis. Digital amputation occurred in 3 undiagnosed cases. There were no differences in maternal characteristics between groups. Estimated fetal weight discordance (p=0.003), GA at FLP (p=0.0004), and chorion-amnion separation (CAS, p<0.0001) differed significantly between cases with and without PABS.
CONCLUSIONS Observed associations with perioperative factors, particularly with CAS, may inform detailed post-FLP evaluation for PABS. Early detection of PABS may facilitate prenatal intervention and reduce adverse neonatal outcomes.
Citation format
LEMOINE, F., et al. Pseudoamniotic band sequence risk factors following fetoscopic laser for twin-twin transfusion syndrome. FETAL DIAGNOSIS AND THERAPY, 2026, 53(4): 1–21.